Procept BioRobotics Profit Margin

The latest profit margin for PRCT is -32.54% as of June 2026. That compares with -30.6% in the prior-year period — down 6.3% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside Procept BioRobotics's historical trend and sector peers before judging valuation or financial health.

Over the past year, PRCT's profit margin moved from -30.6% to -32.54% — a 6.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Procept BioRobotics's valuation or profitability profile.

Against Healthcare companies, PRCT currently prints -32.54% for profit margin, while the sector average sits near 14.41%. That is roughly 325.7% below the sector mean. Large gaps often invite a closer look at Procept BioRobotics's growth, margins, and balance sheet.

Profit Margin shows how effectively Procept BioRobotics converts resources into returns. At -32.54%, PRCT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -30.6% in the prior-year period — down 6.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PRCT's profit margin (-32.54%), review year-over-year change from -30.6%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.